Lina_S

About Lina Silva Salinas

This author has not yet filled in any details.
So far Lina Silva Salinas has created 409 blog entries.

Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study.

2022-07-28T09:41:48+02:00

I. Noordhoek, E. Bastiaannet, N.A. de Glas, J. Scheepens, L.J. Esserman, J. Wesseling, A.N. Scholten, C.P. Schröder, S.G. Elias, J.R. Kroep, J.E.A. Portielje, M. Kleijn, G.J. Liefers. Published: July 21, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.07.006

Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study.2022-07-28T09:41:48+02:00

Updated SIOG COVID-19 working group recommendations on COVID-19 vaccination among older adults with cancer

2022-07-25T09:21:03+02:00

Enrique Soto-Perez-de-Celis, Anna Rachelle Mislang, Celia Gabriela Hernández-Favela, Chiara Russo, Giuseppe Colloca, Grant R. Williams, Shane O'Hanlon, Lisa Cooper, Anita O'Donovan, Riccardo A. Audisio, Kwok-Leung Cheung, Regina Gironés-Sarrió, Reinhard Stauder, Michael Jaklitsch, Clarito Cairo Luiz Antonio Gil Jr, Mahmood Alam, Schroder Sattar, Kumud Kantilal, Kah Poh Loh, Stuart M. Lichtman, Etienne Brain, Hans Wildiers, Ravindran Kanesvaran, Nicolò Matteo Luca Battisti. Published: July 15, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.07.005

Updated SIOG COVID-19 working group recommendations on COVID-19 vaccination among older adults with cancer2022-07-25T09:21:03+02:00

Danish translation and validation of the Geriatric 8 and the modified Geriatric 8 screening tools

2022-07-25T09:13:03+02:00

Helena Møgelbjerg Ditzel, Ann-Kristine Weber Giger, Agon Olloni, Kristoffer Kittelmann Brockhattingen, Cecilia Margareta Lund, Henrik Jørn Ditzel, Per Pfeiffer, Marianne Ewertz, Jesper Ryg, Trine Lembrecht Jørgensen. Published: July 21, 2022 DOI:https://doi.org/10.1016/j.jgo.2022.07.004

Danish translation and validation of the Geriatric 8 and the modified Geriatric 8 screening tools2022-07-25T09:13:03+02:00

Assessing psychological health and social support in older adults with cancer, a how-to guide – A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative

2022-06-16T09:48:55+02:00

Kristen R. Haase, Bonnie Leung, Virginia Sun, Fabio Gomes. Published: June 15, 2022 DOI: https://doi.org/10.1016/j.jgo.2022.05.011

Assessing psychological health and social support in older adults with cancer, a how-to guide – A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative2022-06-16T09:48:55+02:00

5 minutes with the author: The impact of the Modified Frailty Index on clinical outcomes for patients with stage IV non-small cell lung cancer receiving chemotherapy

2022-09-07T07:54:36+02:00

September 5, 2022  Is the Modified Frailty Index useful in patients with metastatic lung cancer?   Frailty involves the impairment of physiologic reserve and ability to maintain homeostasis following a stressor. It is a poor prognostic factor in adults with cancer, but the method used to define frailty has been a moving target.1 In research settings, different definitions used include the phenotypic Fried criteria, a deficit accumulation model defined by a frailty index, or deficits on a comprehensive geriatric assessment.2,3,4 Each of these definitions has integration challenges in a clinical setting. The Modified Frailty Index (mFI) is a brief tool that correlates with post-operative morbidity and mortality in surgical populations.5,6,7 The importance of frailty in patients with metastatic non-small cell lung cancer (NSCLC) receiving chemotherapy remains unclear and the correlation of the mFI with outcomes in this population was unknown. As part of a project [...]

5 minutes with the author: The impact of the Modified Frailty Index on clinical outcomes for patients with stage IV non-small cell lung cancer receiving chemotherapy2022-09-07T07:54:36+02:00

Just in case your patient cannot answer your questions: Screening for severe sarcopenia-related functional impairments with the proxy-reported version of the SARC-F questionnaire

2022-06-22T08:20:45+02:00

June 20, 2022 Journal of Cachexia, Sarcopenia, and Muscle - 2022 Feb;13(1):264-275. doi: 10.1002/jcsm.12871. Sarcopenia is a progressive loss of muscle function and mass that is mostly related to aging [1]. Due to sarcopenia’s adverse outcomes in several conditions, diagnosis and integration into treatment plans is highly recommended [1]. In the care of older adults, cognitive impairment, functional decline, or acute life-threatening medical conditions, such as severe pneumonia, myocardial infarctions, or highly proliferative hematological conditions can preclude patients from self-reported assessment. In addition, a severe acute condition can lead to a massive functional decline within a short time-frame. Thus, physical resilience can be underestimated if a superior premorbid condition is not known to the treating physician. To overcome these barriers, the authors aimed to validate the SARC-F questionnaire, a broadly used screening questionnaire for severe sarcopenia-related functional impairments [2], for the use of proxy-reported information [...]

Just in case your patient cannot answer your questions: Screening for severe sarcopenia-related functional impairments with the proxy-reported version of the SARC-F questionnaire2022-06-22T08:20:45+02:00
Go to Top